Johannes Bange und Dieter - Info zur Person

(1 - 21 von 23

)

Hochwirksame und stabile Nanobodies stoppen SARS- ...Universitätsmedizin Göttingen

www.umg.eu

— ... Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund) und Holm Keller (kENUP Foundation).

Highly potent, stable nanobodies stop SARS-CoV-2 - EurekAlert!www.eurekalert.org › news-releases

www.eurekalert.org

· ... Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund, Germany), and Holm Keller (kENUP Foundation).

Highly potent, stable nanobodies stop SARS-CoV-2Informationsdienst Wissenschaft

idw-online.de

— ... Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund, Germany), and Holm Keller (kENUP Foundation).

Highly potent, stable nanobodies stop SARS-CoV-2Science Daily

www.sciencedaily.com

— ... Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund, Germany), and Holm Keller (kENUP Foundation).

Volume 22, Issue 6, Pages (December 2015) - ppt downloadSlidePlayer

slideplayer.com

... Dieter Haffner, Reimar Abraham, Johannes Bange, Bianca Sperl, Axel Ullrich, Marcus Brand, Myles Wolf, Christian Faul Cell Metabolism Volume 22, Issue 6, ...

Göttinger Forscherteam entwickelt Nanobodies aus Alpakas …

metropolregion.de

WebSep 29, · Unterstützung erhält das Team dabei durch Experten für Technologietransfer: Dieter Link (Max Planck Innovation), Johannes Bange (Lead …

Activation of Cardiac Fibroblast Growth Factor Receptor Johns Hopkins University

pure.johnshopkins.edu

von A Grabner · · Zitiert von: 498 — ... Beatrice Richter, Dieter Haffner, Reimar Abraham, Johannes Bange, Bianca Sperl, Axel Ullrich, Marcus Brand, Myles Wolf, Christian Faul Show 11 others

Cancer progression and tumor cell motility are associated ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von J Bange · · Zitiert von: 368 — Johannes Bange , Dieter Prechtl, Yuri Cheburkin, Katja Specht, Nadia Harbeck, Manfred Schmitt, Tatjana Knyazeva, Susanne Müller, Silvia Gärtner, Irmi Sures, ...

Activation of Cardiac Fibroblast Growth Factor Altmetricdimensions.altmetric.com › d...

dimensions.altmetric.com

... Jörg Stypmann, Christian Kuhn, Susanne Hille, Norbert Frey, Maren Leifheit-Nestler, Beatrice Richter, Dieter Haffner, Reimar Abraham, Johannes Bange, ...

Hochwirksame und stabile Nanobodies stoppen SARS-CoV-2www.it-boltwise.de › hochwirksame-und-stabile-nanobodies-stoppen-sars-c...

www.it-boltwise.de

... für Technologietransfer: Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund) und Holm Keller (kENUP Foundation).

Preclinical Development of U , a Novel FGFR4 ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von R Bartz · · Zitiert von: 14 — ... Alberto Martinez , Masaharu Hanai , Dieter Häussinger , Roger W Chapman , Toshinori Agatsuma , Johannes Bange , Reimar Abraham ...

Original publicationMax-Planck-Gesellschaft

www.mpg.de

The team is supported by experts in technology transfer: Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund, Germany), ...

Hochwirksame und stabile Nanobodies stoppen SARS-CoV-2Max-Planck-Gesellschaft

www.mpinat.mpg.de

— “ Unterstützung erhält das Team dabei durch Experten für Technologietransfer: Dieter Link (Max Planck Innovation), Johannes Bange (Lead ...

Nanobodies: Wirkstoff gegen COVID-19?MT-Dialog

www.mtdialog.de

— ... Dieter Link (Max Planck Innovation), Johannes Bange (Lead Discovery Center, Dortmund) und Holm Keller (kENUP Foundation).

Výsledky vyhledávání - "Roger W Chapman"Akademie věd

katalog.lib.cas.cz

Autor: Reimar Abraham, Johannes Bange, Toshinori Agatsuma, Roger W. Chapman, Dieter Häussinger, Masaharu Hanai, Alberto Martinez, Emi Imai, Hiroyuki Hanzawa ... Autor: Reimar Abraham, Johannes Bange, Toshinori Agatsuma, Roger W. Chapman, Dieter Häussinger, Masaharu Hanai, Alberto Martinez, Emi Imai, Hiroyuki Hanzawa ...

Reimar Abraham
Dieter Link
Marcus Brand

Myles Wolf
Mike Rothe
Henk Born

Personen
Vorname "Johannes" (37739)
Name "Bange" (399)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Johannes Bange und Dieter Person-Info

Hochwirksame und stabile Nanobodies stoppen SARS- ...Universitätsmedizin Göttingen

Highly potent, stable nanobodies stop SARS-CoV-2 - EurekAlert!www.eurekalert.org › news-releases

Highly potent, stable nanobodies stop SARS-CoV-2Informationsdienst Wissenschaft

Highly potent, stable nanobodies stop SARS-CoV-2Science Daily

Volume 22, Issue 6, Pages (December 2015) - ppt downloadSlidePlayer

Göttinger Forscherteam entwickelt Nanobodies aus Alpakas …

Activation of Cardiac Fibroblast Growth Factor Receptor Johns Hopkins University

Cancer progression and tumor cell motility are associated ...National Institutes of Health (.gov)

Activation of Cardiac Fibroblast Growth Factor Altmetricdimensions.altmetric.com › d...

Hochwirksame und stabile Nanobodies stoppen SARS-CoV-2www.it-boltwise.de › hochwirksame-und-stabile-nanobodies-stoppen-sars-c...

Preclinical Development of U , a Novel FGFR4 ...National Institutes of Health (.gov)

Original publicationMax-Planck-Gesellschaft

Hochwirksame und stabile Nanobodies stoppen SARS-CoV-2Max-Planck-Gesellschaft

Nanobodies: Wirkstoff gegen COVID-19?MT-Dialog

Výsledky vyhledávání - "Roger W Chapman"Akademie věd

U 的临床前开发，一种针对癌症的新型FGFR4 抗体x-mol.com

Highly Potent COVID Treatment: New Nanobodies Stop SARS-CoV ...scitechdaily.com › highly-potent-covid-treatment-ne...

Highly potent, stable nanobodies stop SARS-CoV-2www.mpg.de › ... › Newsroom › From the Institutes

Hochwirksame, stabile Nanobodies stoppen SARS-CoV-2

U 的临床前开发，一种针对癌症的新型FGFR4 抗体

Nanobodies stoppen Sars-CoV-2 und dessen neue ...innovationorigins.com

Alle Infos zum Namen "Johannes Bange"